Article
TMEM33 deletion potentiates anti-tumor CD8 <sup>+</sup> T cell immunity
2026-01-02
Abstract excerpt
<h4>ABSTRACT</h4> Improving responses to cancer immunotherapies requires deeper insight into the cellular mechanisms governing T cell-mediated anti-tumor immunity. TMEM33 is an endoplasmic reticulum-resident transmembrane protein enriched across multiple tumor types, with reported functions in anti-viral immunity as well as calcium and lipid homeostasis, yet its role in tumor immunosurveillance remains unknown. U...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- efe2ecd9-4821-5660-9193-89a3df5494a2
- DOI
- 10.64898/2026.01.01.697288
